1. Diagnostic model of combined ceRNA and DNA methylation related genes in esophageal carcinoma
   Xiaojiao Guan et al, 2020, PeerJ CrossRef
2. EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
   Ivana Samaržija et al, 2022, Cancers CrossRef
3. Silencing of LncRNA AFAP1-AS1 Inhibits Cell Proliferation in Oral Squamous Cancer by Suppressing CCNA2
   Tao Li et al, 2021, Cancer Management and Research CrossRef
4. PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
   ZAHRA NASRPOUR NAVAEI et al, 2021, Oncology Research CrossRef
5. Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
   Milad Ashrafizadeh et al, 2020, International Journal of Molecular Sciences CrossRef
6. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis
   Kui Fan et al, 2020, BioMed Research International CrossRef
7. TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis
   Ke Ren et al, 2021, Frontiers in Oncology CrossRef
8. Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies
   Namdev Dhas et al, 2024, Life Sciences CrossRef
9. LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis
   Tao Zuo et al, 2023, Therapeutics and Clinical Risk Management CrossRef